For the purposes of cytometry assays and sorting, we defined CCD133−/CD24+/CD9−as neuronal cancer cells, CD9+/CD44+/CD133− as astro-mesenchymal cancer cells, and CD9+/CD133+ as progenitor cancer cells. This evidence concerns the gene CD44 and cancer.